STOCK TITAN

Carlsmed, Inc. To Participate in the 2026 Canaccord Genuity Musculoskeletal Conference

Carlsmed (Nasdaq: CARL) said CEO and Chairman Mike Cordonnier will present at the 2026 Canaccord Genuity Musculoskeletal Conference on March 2, 2026 at 11:30 AM CST in New Orleans.

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags

Carlsmed (Nasdaq: CARL) said CEO and Chairman Mike Cordonnier will present at the 2026 Canaccord Genuity Musculoskeletal Conference on March 2, 2026 at 11:30 AM CST in New Orleans. A live webcast is available to registered participants and a replay will be posted afterward.

Loading...
Loading translation...
Argus Feb 24 session
+0.08% close to close Open Argus
Details

News Market Reaction – CARL

On Feb 24, the first trading day after this news, CARL closed 0.08% above the previous close.

Data tracked by StockTitan Argus for the Feb 24 session.

Key Figures

Conference date: March 2, 2026 Presentation time: 11:30 AM CST
Conference date
March 2, 2026
Canaccord Genuity Musculoskeletal Conference presentation
Presentation time
11:30 AM CST
Scheduled slot at 2026 Canaccord Genuity Musculoskeletal Conference

Historical Context

5 past events · Latest: Feb 18
5 events
  1. Feb 18

    New procedure milestone

    24h Move
    +6.0%

    First personalized corra cervical plating procedure ahead of commercial launch.

  2. Feb 11

    Earnings date notice

    24h Move
    -5.8%

    Announcement of upcoming Q4 and full-year 2025 results call date.

  3. Feb 10

    New procedure milestone

    24h Move
    -0.1%

    First aprevo lumbar bi-lateral posterior fusion procedure at major hospital.

  4. Jan 12

    Preliminary revenue update

    24h Move
    +13.8%

    Strong preliminary Q4 and 2025 revenue growth versus prior year levels.

  5. Jan 06

    Clinical data publication

    24h Move
    +2.9%

    Peer-reviewed 2-year data showing reduced revision rates with aprevo implants.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

musculoskeletal
1 terms
musculoskeletal medical
"2026 Canaccord Genuity Musculoskeletal Conference on March 2, 2026 at 11:30 AM"
Musculoskeletal relates to the system of bones, muscles, joints, and tissues that support and move the body. It is important to investors because issues or changes in this system can impact the health and productivity of individuals, potentially affecting industries such as healthcare, pharmaceuticals, and insurance. Understanding musculoskeletal health helps gauge broader trends in healthcare spending and workforce well-being.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

CARLSBAD, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced that Mike Cordonnier, CEO and Chairman, will be presenting at the 2026 Canaccord Genuity Musculoskeletal Conference on March 2, 2026 at 11:30 AM CST in New Orleans, LA.  

A live webcast will be available to registered participants. Following the presentation, the webcast replay will be available at https://event.summitcast.com/view/d69xRqMspwymhwGUDdQoes/JC9qqvWhWggYawxGnDNtmz

About Carlsmed, Inc.

Carlsmed is a medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond.

Investor Relations
Caroline Corner, PhD
IR@Carlsmed.com 

Media
LeAnn Burton
Senior Director Brand Marketing
LBurton@Carlsmed.com


FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Carlsmed (CARL) present at the 2026 Canaccord Genuity Musculoskeletal Conference?

Carlsmed will present on March 2, 2026 at 11:30 AM CST. According to Carlsmed, CEO Mike Cordonnier is scheduled to speak in New Orleans with a live webcast option for registered attendees and a replay posted after the presentation.

How can investors watch Carlsmed's (CARL) presentation on March 2, 2026?

Investors can view a live webcast with registration. According to Carlsmed, a live webcast will be available to registered participants and a replay will be posted afterward at the provided webcast URL for on-demand viewing.

Who will represent Carlsmed (CARL) at the Canaccord Musculoskeletal Conference 2026?

Mike Cordonnier, Carlsmed's CEO and Chairman, will present at the event. According to Carlsmed, Cordonnier will deliver the company presentation on March 2, 2026, offering an executive update to attendees and webcast viewers.

Where is the 2026 Canaccord Genuity Musculoskeletal Conference presentation by CARL being held?

The presentation will take place in New Orleans, Louisiana. According to Carlsmed, the company’s session is scheduled at the conference venue on March 2, 2026 at 11:30 AM CST with online access via webcast.

Will a replay of Carlsmed's (CARL) March 2, 2026 presentation be available online?

Yes, a replay will be posted for later viewing at the webcast link. According to Carlsmed, the webcast replay will be available after the live presentation at the event’s provided URL for registered and subsequent viewers.

Keep reading